GlaxoSmithKline UK

Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Patient Information Leaflet last updated on the eMC: 07/02/2012
PIL Requip Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 07/02/2012 and displayed until Current
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change to date of revision
Updated on 07/02/2011 and displayed until 07/02/2012
Reasons for adding or updating:
  • Change to packaging
  • Change to date of revision
  • Change to manufacturer contact details
Updated on 15/04/2010 and displayed until 07/02/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 26/02/2010 and displayed until 15/04/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 24/09/2009 and displayed until 26/02/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 16/12/2008 and displayed until 24/09/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change due to user-testing of patient information
Updated on 30/03/2007 and displayed until 16/12/2008
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to side-effects
  • Change to warnings or special precautions for use
  • Change to information about driving or using machinery
  • Change to Further Information section
  • Change to date of revision
  • Change to manufacturer contact details
  • Change to name of manufacturer
Updated on 09/03/2007 and displayed until 30/03/2007
Reasons for adding or updating:
  • Change to date of revision
  • Company name change or merger
Updated on 09/05/2002 and displayed until 09/03/2007
Reasons for adding or updating:
  • Update to PIL
Updated on 03/05/2001 and displayed until 09/05/2002
Reasons for adding or updating:
  • No reasons supplied
Updated on 20/10/2000 and displayed until 03/05/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 10/08/2000 and displayed until 20/10/2000
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   ropinirole hydrochloride